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The Streptomyces clavuligerus clavam gene
cluster was examined to identify genes specifi-
cally involved in 5S clavam biosynthesis. A
reduction/loss of 5S clavam production was
seen in cvm2 and cvm5 gene mutants, and
a clavam metabolite not previously observed,
2-carboxymethylideneclavam, accumulated in
the cvm5mutant. Disruption of additional genes
from the region of the clavam cluster did not
have any effect on 5S clavam production.
Examination of the paralog gene cluster region
for 5S clavam biosynthetic genes led to the
identification of cvm6P and cvm7P, which
encode a putative aminotransferase and a tran-
scriptional regulator, respectively. Mutants
defective in cvm6P and cvm7Pwere completely
blocked in 5S clavam but not clavulanic acid
production. The loss of 5S clavam production
in cvm7P mutants suggests that this gene
encodes a transcriptional regulator specific for
5S clavam metabolite biosynthesis.
INTRODUCTION
Streptomyces clavuligerus is well known as the species
used for the industrial production of the b-lactam metabo-
lite, clavulanic acid. Due to its ability to inhibitmany b-lacta-
mases, clavulanic acid is usedclinically in combinationwith
other b-lactam antibiotics to combat antibiotic resistant
infections caused by b-lactamase-producing bacteria [1].
In addition to clavulanic acid,S. clavuligerus also produces
penicillin and cephamycin antibiotics, as well as four more
clavam metabolites, collectively referred to as the 5S
clavams due to their 5S stereochemistry [2, 3] (Figure 1).
In contrast, clavulanic acid has a 3R, 5R configuration [4].Chemistry & Biology 14, 131–1The biosynthetic pathway leading to clavulanic acid and
the 5S clavams is partially shared in S. clavuligerus, at
least up to the level of clavaminic acid [5] (Figure 1). Al-
though the early, shared part of this pathway has been
well studied, little is known about the late steps beyond
clavaminic acid that lead specifically to clavulanic acid
or the 5S clavams. The last reaction in clavulanic acid
biosynthesis involves the conversion of clavaldehyde
into clavulanic acid [6], and recently, the enzymeN-glycyl-
clavaminic acid synthetase, which converts clavaminic
acid to N-glycyl-clavaminic acid [7], was identified; how-
ever, details of the intervening reactions remain unclear,
and none of the reactions involved in the late steps of 5S
clavam biosynthesis has as yet been elucidated.
The 3R, 5R stereochemistry of clavulanic acid is associ-
ated with its b-lactamase inhibitory activity, as both clavu-
lanic acid and clavaldehyde share this stereochemistry
and are inhibitory. In contrast, the 5S clavams show a vari-
ety of weak antifungal and antibacterial activities, but are
not b-lactamase inhibitors [8]. In the industrial production
of clavulanic acid, the 5S clavams represent unwanted
contaminants that consume metabolic resources and
complicate downstream processing. Therefore, elimina-
tion of 5S clavam production while retaining full clavulanic
acid productivity is one reason to seek a full understanding
of the interrelationship between clavulanic acid and 5S
clavam metabolite biosynthesis. The observation that
both clavaldehydeandclavulanic acid arebioactive is con-
sistentwithprevious studies showing that variations in side
chains at the C2 position are compatible with b-lactamase
inhibition [4]. Since the 5S clavams differ from each other
and from clavulanic acid in their C2 side chains, this raises
the additional possibility that the enzymes for 5S clavam
biosynthesis may provide a biological route to the produc-
tion of clavulanic acid analogs with altered C2 side chains.
However, a full understanding of the late stages of clavu-
lanic acid and 5S clavam biosynthesis is first required.
The biosynthesis of several large classes of antibiotics,
such as the polyketides and nonribosomal peptides,42, February 2007 ª2007 Elsevier Ltd All rights reserved 131
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S. clavuligerus 5S Clavam Biosynthetic GenesFigure 1. The Clavulanic Acid and 5S
Clavam Biosynthetic Pathway in
S. clavuligerus
Solid lines represent known steps and broken
lines indicate multiple intermediates or un-
known portions of the pathway. Structures
and enzymes shown in gray are hypothetical.follows such conserved patterns that the biosynthesis of
newly discovered metabolites in these classes can be
largely predicted from translation of gene sequences
alone. In contrast, the b-lactams are less widespread in
nature, and each subgroup follows a separate biosyn-
thetic route. As a result, details of clavam metabolite
biosynthesis cannot be inferred from known pathways.
Furthermore, since the reactions giving rise to the final
products are unknown, gene sequences have little predic-
tive value, and genes involved in biosynthesis can only be
identified by mutating each candidate individually.
The genes involved in the biosynthesis of clavulanic
acid and the 5S clavams reside in at least three separate
locations on the S. clavuligerus chromosome [9] (Fig-
ure 2A). The clavulanic acid gene cluster is located next
to the cephamycin C gene cluster [10]. It comprises the
ceaS2, bls2, pah2, cas2, and oat2 genes, all involved in
the biosynthesis of clavaminic acid and, therefore, con-
tributing to the production of both clavulanic acid and
the 5S clavams, along with additional genes involved in
the formation of clavulanic acid only [11–15]. However,
genes encoding enzymes for the early shared part of
the pathway are each present in two copies on the132 Chemistry & Biology 14, 131–142, February 2007 ª2007S. clavuligerus chromosome [16–18] (Figure 2A). cas1,
encoding a second form (paralog) of clavaminate syn-
thase, does not reside together with cas2 in the clavulanic
acid gene cluster, but instead is located separately [17].
The region surrounding cas1 is referred to as the clavam
gene cluster, since mutants defective in genes from this
region have lost 5S clavam but not clavulanic acid produc-
tion [19]. The paralogs of the ceaS2, bls2, pah2, and
oat2 genes are not located in either the clavulanic acid
or the clavam gene clusters. Instead, they form yet an-
other gene cluster—the paralog cluster [18] (Figure 2A).
In the present study, we examined the regions of the
S. clavuligerus chromosome in the vicinity of the clavam
and paralog gene clusters to identify additional genes
that are involved in the biosynthesis and regulation of
the 5S clavams.
RESULTS
Isolation and Analysis of Genes from the Clavam
Gene Cluster
In a previous study, Mosher et al. [19] identified four genes
(cvm1, cvm2, cvm4, and cvm5) and partially sequencedElsevier Ltd All rights reserved
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S. clavuligerus 5S Clavam Biosynthetic GenesFigure 2. Genes Involved in the
Biosynthesis of Clavam Metabolites in
S. clavuligerus
(A) Diagrammatic representation of the three
gene clusters involved in clavulanic acid
and 5S clavam metabolite biosynthesis in
S. clavuligerus. Gray arrows represent previ-
ously sequenced genes, whereas black arrows
indicate genes identified in the present study,
and arrowheads indicate the direction of
transcription (not drawn to scale). The location
of the cephamycin gene cluster and genes
specific for clavulanic acid biosynthesis are
also indicated. Restriction endonuclease sites
used to subclone DNA fragments for sequenc-
ing are also shown. B, BamHI; K, KpnI; N;NcoI;
S, SalI and Sp, SphI.
(B) Diagrammatic representation of the region
corresponding to the clavam gene cluster in
S. coelicolor, S. avermitilis, and S. violaceo-
ruber (not to scale). The designation and anno-
tation of some homologous ORFs are shown.
The broken line represents the region
corresponding to the clavam gene cluster in
S. clavuligerus, and the relative sizes (in kb) of
these regions in S. coelicolor, S. avermitilis,
and S. violaceoruber are indicated.two open reading frames (ORFs; cvm3 and cvm6) located
in the vicinity of the cas1 gene in S. clavuligerus. This
group of genes was named the clavam cluster because
cvm1 and cvm4-cvm5 mutants did not produce any 5S
clavams, while clavulanic acid production was unaffected
[19]. Due to the apparent involvement of cvm1 and cvm4-
cvm5 in 5S clavam production, the region surrounding the
known clavam gene cluster was investigated to search for
additional genes involved in 5S clavam production.
The cosmid clones 10D7 [19] and p53 (Jensen et al., un-
published data), which contain DNA inserts from the re-
gions upstream and downstream of the known clavam
gene cluster (Figure 2A), were used to isolate smaller
restriction fragments for DNA sequencing. DNA inserts
within the cosmids were compared with chromosomal
DNA by Southern analysis to confirm that no rearrange-
ments had occurred during cosmid isolation. In total,
nine new ORFs and a tRNA gene were identified, extend-
ing the known sequence of the S. clavuligerus clavam
gene cluster to 23.3 kb (Figure 2A and Table 1). The
remaining DNA sequence of the previously incomplete
cvm3 and cvm6 genes was also obtained [19]. The pre-
dicted Cvm3 gene product contains a flavin reductase-
like FMN-binding domain typical of reductases associated
with mono-oxygenases involved in secondary metabolite
biosynthesis [20, 21], although the highest degree of
similarity was shown by a flavin reductase-like protein
from Novosphingobium aromaticivorans. The sequenceChemistry & Biology 14, 131of cvm6 revealed that it encodes a putative class-III
aminotransferase similar to ornithine/acetylornithine ami-
notransferases (ArgD) that catalyze the transfer of an
amino group from acetylornithine to a-ketoglutarate [22].
Seven of the newly sequenced ORFs lie downstream of
cvm3 at the left end of the clavam cluster and include two
potential transcriptional regulators (Figure 2A and Table
1). The Cvm7 gene product has an unusual two-domain
structure, but shows end-to-end similarity to the tran-
scriptional regulator, PimR, from S. natalensis [23]. The
N-terminal domain resembles transcriptional activators
of the Streptomyces antibiotic regulatory protein (SARP)
type, while the C-terminal domain contains a tetratrico-
peptide repeat sequence typically found in LuxR-type
regulators. The Cvm12 gene product is predicted to
contain a gluconate operon transcriptional repressor
(GntR)-type winged helix-turn-helix domain. In addition,
amino acids 145–389 show the presence of a class I and
class II aminotransferase binding motif similar to tran-
scriptional regulators of unknown function from the
MocR subfamily of GntR regulators [24].
cvm11 (Figure 2A), lies between cvm7 and cvm12, and
encodes an integral membrane protein similar to the
LysE and RhtB-type translocator family of proteins in-
volved in lysine and threonine export [25]. The four ORFs
downstream of cvm12 include cvm13, encoding an aspar-
aginase-like protein, cvmH, encoding a thioesterase-like
protein, and cvmP, the predicted gene product of which–142, February 2007 ª2007 Elsevier Ltd All rights reserved 133
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S. clavuligerus 5S Clavam Biosynthetic GenesTable 1. Predicted Functions for Previously Unreported or Partially Sequenced ORFs from the Clavam and the
Paralog Gene Clusters of Streptomyces clavuligerus
Gene Cluster Most Similar Protein, Source, Accession Number,
Similarity/IdentitybORF Size (aa)a Proposed Functionc
cvm2d Clavam, 151 Hypothetical protein, Ralstonia eutropha,
AAZ64037, 60/47
Isomerase
cvm3e Clavam, 188 Putative flavin reductase, Novosphingobium
aromaticivorans, EAP38005, 65/49
Flavin Reductase
cvm4d Clavam, 328 Putative homoserine acetyltransferase,
Burkholderia fungorum, ZP_00284696, 56/41
Acetyltransferase
cvm5d Clavam, 394 Putative oxidoreductases, Novosphingobium
aromaticivorans, EAP37999, 52/35
Mono-oxygenase/Oxidoreductase
cvm6e Clavam, 442 Putative aminotransferase from Chloroflexus
aurantiacus, EAO57759, 57/42
Aminotransferase
cvm7 Clavam, 1114 Pimaricin regulator PimR, Streptomyces natalensis,
CAE51066, 45/32
Transcriptional regulator
cvm9 Clavam, 182 Gra-orf8, Streptomyces violaceoruber, CAA09629,
96/94
Transcriptional regulator
cvm10 Clavam, NAf Gra-orf7, Streptomyces violaceoruber, CAA09628,
96/89
Protein Kinase
cvm11 Clavam, 216 Putative LysE family translocator, Nocardia
farcinica, Q5Z268, 63/52
Efflux Protein
cvm12 Clavam, 445 Transcriptional regulatory protein from
Bradyrhizobium japonicum, Q89HX9, 63/49
Transcriptional regulator
cvm13 Clavam, 390 Putative asparaginase YbiK, Shigella flexneri,
AAN42412, 53/40
Asparaginase
cvmH Clavam, 305 LanU-like protein, Streptomyces murayamaensis,
AAO65353, 60/51
Hydrolase
cvmP Clavam, 687 Putative protein-arginine deiminase, Gibberella
zeae, EAA72393, 53/39
Arginine deiminase
cvmG Clavam, 92 Gra-orf36, Streptomyces violaceoruber,
CAA09663, 39/32
Putative secreted protein
cvm6P Paralog, 437 Cvm6, the clavam gene cluster of Streptomyces
clavuligerus, 73/63
Aminotransferase
cvm7P Paralog, 818 Pimaricin regulator PimR, Streptomyces natalensis,
CAE51066, 31/23
Transcriptional regulator for 5S clavams
a aa, number of amino acids predicted in the encoded protein.
b Percent similarities/identities were determined using the online BLASTp program.
c Proposed functions are based on predicted motifs and on the functions of the most similar proteins present in GenBank.
d The DNA sequence of these ORFs has been reported previously [19] and are included because they were subjected to gene
disruption analysis in this study.
e The partial DNA sequence of these ORFs has been reported previously [19].
f NA, not applicable as only the partial DNA sequence of the ORF is known.contains a partial protein-arginine deiminase (PAD) motif.
In mammals, PADs modify protein-bound arginine resi-
dues to citrulline, but their function in prokaryotes is
yet to be demonstrated [26]. The most downstream ORF
to be sequenced was cvmG, encoding a hypothetical
protein of unknown function, but similar to gra-orf36, a
gene locatedatoneedgeof thegranaticingenecluster [27].
On analysis of the genes beyond cvm6 at the right end
(Figure 2A) of the clavam cluster, an alanyl-tRNA gene134 Chemistry & Biology 14, 131–142, February 2007 ª2007(tRNAala), and two ORFs, cvm9, the gene product of which
is virtually identical to a hypothetical protein encoded by
gra-orf8, and cvm10 (partial sequence only), resembling
the putative serine-threonine protein kinase, gra-orf7,
were discovered. These three genes show identical ar-
rangement to the tRNAala, gra-orf7 and gra-orf8 genes
found at the other edge, opposite to gra-orf36, in the gran-
aticin biosynthetic gene cluster of S. violaceoruber [27]
(Figure 2B).Elsevier Ltd All rights reserved
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S. clavuligerus 5S Clavam Biosynthetic GenesFigure 3. Preparation and Analysis of the cvm2 Mutant
(A) Diagrammatic representation of the process leading to the isolation of the cvm2 mutant using a specific gene-targeting plasmid. The gray bar
represents the S. clavuligerus chromosome, white arrows represent cvm2, and black arrows represent the disruption cassette. The antibiotic
resistance profiles of wild-type S. clavuligerus containing disruption vector and the cvm2 mutant are also indicated. Terms aprr, tsrr, and tsrs refer
to apramycin- or thiostrepton-resistant or -sensitive phenotypes, respectively.
(B) HPLC analysis of the cvm2 mutant. The identities of the various clavam metabolites produced by wild-type S. clavuligerus and the cvm2 mutant
are indicated.Preparation of Mutants from the Clavam
Gene Cluster
Activities can be inferred for some of the nine new ORFs
identified in the region of the clavam gene cluster (Table
1), but actual functions for natural product biosynthetic
genes can be quite different from what might be predicted
based on primary sequence homology. Therefore, gene
disruption mutants were prepared to determine if they
are involved in clavulanic acid and/or 5S clavam metabo-
lite biosynthesis. Although cvm2 had been sequenced
previously [19], it had not been subjected to mutational
analysis. Therefore, a cvm2 mutant was prepared by
a modified version of the polymerase chain reaction
(PCR) targeting procedure [28] (Figure 3A). Analysis of
the cvm2 mutant revealed that it was severely compro-
mised in alanylclavam and 2-hydroxymethylclavam
synthesis, and totally blocked in clavam-2-carboxylate
production (Figure 3B).
Mosher et al. [19] reported the partial DNA sequence of
cvm3 and cvm6, but did not prepare mutants defective in
these ORFs. They also prepared a mutant in which both
cvm4 and cvm5 were deleted together, and found that
this mutant did not produce any of the 5S clavams. There-
fore, it was not clear which of cvm4 or cvm5 was respon-
sible for the observed phenotype. To investigate further
the roles of cvm3, cvm4, cvm5, and cvm6 in 5S clavam
metabolite biosynthesis, individual mutants were pre-
pared in each of the ORFs by insertion of apramycin
(apr) or neomycin (neo) resistance genes within their
coding regions, oriented in the same direction of
transcription. Analysis of soy culture supernatants from
cvm3, cvm4, and cvm6 mutant cultures indicated that
they all still produced wild-type levels of clavulanic acid
and 5S clavams (data not shown).Chemistry & Biology 14, 131High-pressure liquid chromatography (HPLC) analysis
of cvm5 mutant cultures showed that production of the
known 5S clavamswas completely blocked in this mutant,
but that a new clavammetabolite (retention time, 6.13min)
had accumulated (Figure 4A). Once recognized, the new
clavam metabolite was also noted to be present at low
levels in supernatants from the wild-type strain. Liquid
chromatography-mass spectrometry (LC-MS) analysis of
imidazole-derivatized soy culture supernatants confirmed
the accumulation of this metabolite in the cvm5 mutant
cultures (retention time, 13.68; m/z = 238) (Figure 4A).
Furthermore, LC-MS-MS analyses identified fragments
with m/z values of 238, 170, 152, 126, 110, 98, and 84
(Figure 4B), which led to the predicted structure of the
novel clavam, tentatively named 2-carboxymethylidene-
clavam, as shown in Figure 4C, structures 1 and 2. The
two possible structures for this metabolite could not be
distinguished by this analysis, since the imidazole deriva-
tization procedure used for HPLC analysis would remove
a C3 COOH group, if present.
Sequence analysis of cvm7 indicated that its predicted
protein product would contain two distinct domains: an
N-terminal SARP-like domain and a C-terminal LuxR-like
domain. Two cvm7 knockout mutants were prepared by
the insertion of apr at 130 bp, in the SARP-like region,
and at 2064 bp, in the LuxR-like region, of the predicted
ORF. On fermentation analysis, it was found that both
types of mutants produced clavulanic acid and 5S
clavams at levels comparable to the wild-type strain, indi-
cating that Cvm7was not involved in regulating 5S clavam
biosynthesis.
Mutants defective in cvm9, cvm10, cvm11, cvm12,
cvm13, cvmP, and cvmG were also prepared by PCR
targeting, or by the insertion of apr within their coding–142, February 2007 ª2007 Elsevier Ltd All rights reserved 135
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S. clavuligerus 5S Clavam Biosynthetic GenesFigure 4. Identification of the Clavam Metabolite Accumulating in the cvm5 Mutant
(A) LC-MS analysis of cvm5 mutant culture supernatants after imidazole derivatization showing the UV absorbance (PDA) and scan for mass
(m/z = 238).
(B) Tandem LC-MS-MS analysis of the peak corresponding tom/z = 238 showing its fragmentation pattern.
(C) Deduced structures of the possible compounds capable of giving the parent ion seen in (A) and corresponding to the fragmentation pattern
seen in (B).regions, but none of the mutants was affected in clavu-
lanic acid or 5S clavam metabolite production. Mutation
of cvmH was also attempted, but disruption constructs
were unstable and did not lead to the isolation of cvmH
mutants despite repeated attempts.
Isolation and Analysis of Genes from the Paralog
Gene Cluster
Preparation and analysis of thirteen new mutants from the
clavam gene cluster revealed that only the cvm2 and cvm5
disruptionmutants had observable phenotypes in terms of
5S clavam production, in addition to the previously
described cvm1 mutant. This led us to conclude that any
additional biosynthetic genes needed to form the four 5S
clavam metabolites are likely to be located elsewhere on
the chromosome.
To investigate the possibility that genes involved in the
later stages of 5S clavam metabolite biosynthesis might
reside in the vicinity of the paralog gene cluster, additional
ORFs from the region downstream from oat1 were
analyzed. The corresponding region downstream from
oat2 in the clavulanic acid gene cluster comprises the
rest of the clavulanic acid biosynthetic genes. DNA
sequence was obtained from restriction fragments subcl-
oned from the cosmid 14E10 and from a 4.3-kb NcoI
genomic DNA fragment cloned previously by Jensen
et al. [16], leading to the identification of two new ORFs,
cvm6P and cvm7P (Figure 2A).
The putative Cvm6P gene product shares 73% end-
to-end similarity with Cvm6 from the clavam gene cluster,
and, like Cvm6, it resembles the ArgD protein (Table 1).
cvm7P, located upstream of cvm6P (Figure 2A), encodes136 Chemistry & Biology 14, 131–142, February 2007 ª2007 Ea putative bipartite transcriptional regulator. Once again,
the predicted Cvm7P gene product is so-named because
it shares 30% end-to-end similarity with Cvm7 from the
clavam gene cluster, and, therefore, also resembles the
pimaricin regulator, PimR [23] (Table 1).
Preparation of Mutants from the Paralog
Gene Cluster
cvm6P mutants were prepared by the insertion of neo
within the ORF, in the same orientation as the gene.
Fermentation analysis showed that production of the 5S
clavams was abolished in the cvm6P mutants, whereas
clavulanic acid and cephamycin C production was unaf-
fected (data not shown).
A cvm7P mutant strain was prepared using the PCR
targeting system, as described earlier [28]. HPLC analysis
of culture supernatants showed that the cvm7P mutant
and the wild-type strains produced similar levels of clavu-
lanic acid. Like the cvm6Pmutants, bioassays and LC-MS
indicated that the cvm7Pmutants did not produce detect-
able levels of any of the 5S clavams (data not shown).
DISCUSSION
Genes involved in the biosynthesis of 5S clavam metabo-
lites in S. clavuligerus have been located in the clavam
gene cluster, but many steps in the proposed biosynthetic
pathway have no corresponding genes in this cluster, and
no transcriptional regulators specific for 5S clavam pro-
duction are known. Therefore, the DNA sequence of the
S. clavuligerus clavam gene cluster was extended, and
mutants defective in genes from flanking regions werelsevier Ltd All rights reserved
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S. clavuligerus 5S Clavam Biosynthetic Genesprepared and analyzed to assess their involvement in 5S
clavam biosynthesis. Examination of the cvm2 mutant
prepared in this study showed that the production of the
5S clavams was greatly reduced (alanylclavam and 2-
hydroxymethylclavam) or completely eliminated (clavam-
2-carboxylate). The predicted amino acid sequence of
Cvm2 is similar to proteins possessing ketosteroid isom-
erase-like domains. Ketosteroid isomerases are involved
in the intramolecular transfer of protons resulting in the
isomerization of steroids [29], essential steps in steroid
biosynthesis in mammals; however, in bacteria these
enzymes are linked to the degradation of steroids [30].
The reason for involving an isomerase in 5S clavam bio-
synthesis is unknown, but it is clearly important, sincemu-
tation severely reduced the level of 5S clavams produced.
The predicted Cvm5 gene product resembles flavin-
dependent mono-oxygenases [19] that utilize reduced
flavin provided by a flavin reductase. The best matches
for Cvm5 found by BLAST analysis were luciferase-like
mono-oxygenases from Sphingomonas and Novosphin-
gobium spp. Similarly, the predicted Cvm3 gene product
resembles flavin reductases, and themost similar proteins
by BLAST analysis are the flavin reductases from Sphin-
gomonas and Novosphingobium spp., which partner
with their corresponding mono-oxygenases. Therefore,
Cvm3 presumably functions to provide reduced flavin
to Cvm5.
Analysis of the cvm5 mutant showed that it did not
produce any of the known 5S clavams. Instead, there
was accumulation of a novel clavam, 2-carboxymethyli-
deneclavam. Since this novel clavam is also present in
small amounts in the wild-type, it may be an intermediate
in 5S clavam biosynthesis. Furthermore, since the cvm5
mutant produces none of the known 5S clavam products,
Cvm5 must function soon after clavaminic acid in the 5S
arm of the branched pathway. The lack of a phenotype
for the cvm3 mutants is inconsistent with Cvm3 being
required for Cvm5 activity. However, the flavin reductase
merely provides reduced FAD or FMN to the mono-
oxygenase, and so, perhaps, other flavin reductases
may take its place, as has been shown for SnaC, which
can functionally replace ActVB in the biosynthetic path-
way leading to actinorhodin [21].
In considering reactions that could give rise to 2-
carboxymethylideneclavam, an aminotransferase-type
activity could convert the amino group at C2 of clavami-
nate to the corresponding aldehyde, which would then
be oxidized to give the carboxylic acid seen in 2-carboxy-
methylideneclavam (Figure 1). Alternatively, 2-carboxy-
methylideneclavam may be a shunt product arising from
an attack on the proposed reactive aldehyde by a nonspe-
cific oxygenase/dehydrogenase. However, assuming that
2-carboxymethylideneclavam is a true pathway interme-
diate, the Cvm3/Cvm5 couple, alone or in combination
with other gene products, must then further convert 2-car-
boxymethylideneclavam into 2-formyloxymethyl clavam
and subsequent products of the 5S pathway, as proposed
by Egan et al. [5]. Although the putative Cvm6 gene
product resembles aminotransferases, we were unableChemistry & Biology 14, 131to establish a role for Cvm6 in clavam biosynthesis, as
cvm6 mutants showed no phenotype.
We also prepared and analyzed a mutant defective in
the previously reported cvm4 gene, as Mosher et al. [19]
showed that a cvm4-cvm5 double mutant did not produce
any of the 5S clavams. Examination of the new cvm4
mutant revealed that it was not affected in either clavulanic
acid or 5S clavam metabolite biosynthesis, indicating that
the defect in 5S clavam production seen earlier in the
cvm4-cvm5 double mutant [19] was due solely to the dis-
ruption of cvm5. The predicted Cvm4 gene product
resembles homoserine O-acetyltransferases [19], which
transfer acetate from acetyl-CoA to homoserine [31] dur-
ing methionine biosynthesis in some bacteria. Examina-
tion of the S. coelicolor and S. avermitilis genomes sug-
gests that these streptomycetes do not use homoserine
O-acetyltransferases, but instead channel cysteine and
serine into the methionine biosynthetic pathway via cysta-
thionine g-lyase and cystathionine b-synthase, respec-
tively. In keeping with this, mutagenesis of cvm4 did
not lead to methionine auxotrophy in S. clavuligerus
(data not shown). cvm4 also shows a lesser degree of
similarity (46% over 156 aa) to cefG, encoding the acetyl-
transferase involved in formation of cephalosporin C
in Acremonium chrysogenum [32]. However, no corre-
sponding reaction is involved in the production of cepha-
mycin C in S. clavuligerus, and the disruption of cvm4 had
no effect on cephamycin C production. Despite the lack
of phenotype for cvm4 mutants, the location of cvm4
in the clavam gene cluster suggests that it may play a
conditional role in 5S clavam biosynthesis.
Other ORFs identified in this study from the region
surrounding the clavam gene cluster were also subjected
to insertional inactivation. Results showed that none of
the putative transcriptional regulators located in this
region affect 5S clavam production. Therefore, it is
predicted that these ORFs are not directly involved in 5S
clavam biosynthesis.
The disruption of cvmG, cvm9, and cvm10 from the
clavam gene cluster (Figure 2A), which are very similar to
gra-orf36, gra-orf8, and gra-orf7, respectively (Table 1),
genes flanking either edge of the granaticin biosynthetic
gene cluster of S. violaceoruber [27], did not affect 5S
clavam production. Examination of the S. coelicolor [33]
and S. avermitilis [34] genome sequences showed that
gra-orf36, gra-orf8, and gra-orf7 homologs are also found
in these organisms, suggesting that they are not true gran-
aticin biosynthetic genes but merely flank the cluster in
S. violaceoruber (Figures 2A and 2B). The location of
these genes on the chromosomes of S. coelicolor and
S. avermitilis can give insights into the presumptive loca-
tions of the clavam and granaticin gene clusters in the
genomes of S. clavuligerus and S. violaceoruber. In both
S. coelicolor and S. avermitilis, the gra-orf36 and gra-
orf8 homologs are located within the conserved core of
the chromosome near the origin of replication and sepa-
rated from each other by only about 2 kb. In contrast, in
S. violaceoruber and S. clavuligerus, they are separated
by the intervening granaticin (34.59 kb) or clavam–142, February 2007 ª2007 Elsevier Ltd All rights reserved 137
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S. clavuligerus 5S Clavam Biosynthetic Genes(21.05 kb) gene clusters, respectively (Figures 2A and 2B).
The discrepancies between these species in this region of
the genome suggests that S. violaceoruber and S. clavuli-
gerus might have acquired their granaticin and clavam
gene clusters by horizontal gene transfer, by incorporating
them into a hot spot for the insertion of exogenous DNA
found at this chromosomal locus. All four of these Strepto-
myces species contain one or more tRNA genes in this
region (Figures 2A and 2B), genes often associated with
insertions and rearrangements of genetic material in bac-
teria [35]. Comparative analysis of clavam biosynthetic
gene clusters from other producer species should help
shed light on this hypothesis.
Since further examination of the clavam gene cluster did
not uncover any genes involved in regulation or in the
specific late steps of 5S clavam production, we explored
the possibility that additional genes involved in the biosyn-
thesis of these metabolites might reside in the paralog
gene cluster. The sequence of the known paralog gene
cluster was extended, leading to the isolation of cvm6P
and cvm7P (Figure 2A). These genes are similar to their
counterparts, cvm6 and cvm7, genes from the clavam
gene cluster. Cvm6P, like Cvm6, resembles pyridoxal-
50-phosphate (PLP)-dependent ArgDs (Table 1). The crys-
tal structure of human ArgD (ArgDHS) has been solved,
showing that the active site comprises R180, E235, and
R413 residues, with PLP covalently bound to K292 [36].
The predicted amino acid sequences of Cvm6 and
Cvm6P contain sites for the covalent attachment of PLP
(K280 and K267, respectively), but lack two of the three
above-mentioned active-site residues, with only E184
(= E235HS) being conserved. In comparison, the predicted
S. clavuligerus ArgD contains the K246 residue for PLP
attachment and the active site residues R135, E189, and
R363 [37]. Therefore, it is possible that Cvm6 and/or
Cvm6P function as aminotransferases, but with a sub-
strate other than ornithine/acetylornithine. While disrup-
tion of cvm6 had no effect on 5S clavam biosynthesis,
production was completely abolished in the cvm6P
mutant, indicating that the two gene products have differ-
ent activities in S. clavuligerus. If 5S clavam biosynthesis
proceeds by deamination of clavaminic acid, Cvm6P
may represent the aminotransferase responsible for this
reaction.
During arginine biosynthesis in Streptomyces spp.,
ArgD catalyzes the transamination of N-acetylglutamyl-
g-semialdehyde to give N-acetylornithine, which is then
converted to ornithine by the action of OAT (ArgJ), thereby
recycling the acetyl group [22]. Within the paralog cluster,
cvm6P (similar to argD) resides next to oat1 (Figure 2A),
which has been proposed to encode an unusual OAT-
like protein (similar to ArgJ) [38, 39]. Therefore, the puta-
tive transamination activity encoded by cvm6P, which is
essential for 5S clavam biosynthesis, may also be coupled
to an acetylation activity encoded by oat1, although
neither OAT1 nor -2 activity is essential for clavam
biosynthesis [18].
The cvm7P gene, like cvm7, encodes a putative tran-
scriptional regulator similar to the pimaricin regulator138 Chemistry & Biology 14, 131–142, February 2007 ª2007 Efrom S. natalensis [23] (Table 1). While mutation of cvm7
had no discernable phenotype, disruption of cvm7P
resulted in the loss of all of the 5S clavams, with no effect
on clavulanic acid. Therefore, Cvm7P apparently func-
tions as a pathway-specific regulator for 5S clavam
biosynthesis, analogous to ClaR in clavulanic acid biosyn-
thesis [40], making it the first 5S clavam-specific transcrip-
tional regulator to be identified. The Cvm7P regulon is
currently under investigation to determine whether it
extends beyond the paralog cluster to include clavam
and clavulanic acid cluster genes, and to determine if
Cvm7P regulates the production of the 5S clavams
directly or indirectly. Since pathway-specific transcrip-
tional regulators involved in antibiotic biosynthesis are
normally located within their respective biosynthetic
gene clusters, studies are also being carried out to isolate
and characterize additional ORFs from the region of the
paralog gene cluster to determine if they are involved in
the biosynthesis of the 5S clavams.
With the discovery of the cvm6P and cvm7P genes, it
becomes apparent that the paralog gene cluster not only
contains paralogs to genes from the clavulanic acid
gene cluster (ceaS1, bls1, pah1, and oat1), but also to
genes from the clavam gene cluster (Figure 2A). However,
while the paralogous ceaS1-2, bls1-2, pah1-2, and oat1-2
genes can functionally replace each other in clavulanic
acid and 5S clavam metabolite biosynthesis [18], the
same is not true for the cvm6-cvm6P and the cvm7-
cvm7P genes. Only cvm6P and cvm7P are functional rel-
ative to their counterparts from the clavam gene cluster.
Perhaps the proximity of cvm6P and cvm7P to the ‘‘early’’
biosynthetic genes from the paralog gene cluster is impor-
tant for coregulation and/or coordination of enzymatic
activities. Alternatively, since cvm6- and cvm7-type genes
are represented twice, the redundant genes from the
clavam gene cluster may have lost their functionality
over time, and only the genes specifically required for
biosynthesis remained intact.
SIGNIFICANCE
The Streptomyces clavuligerus clavam and paralog
geneclustersbothcontaingenes involved in5Sclavam
metabolite biosynthesis. Genes identified from the
clavamgene cluster included a two-component flavin-
dependent mono-oxygenase complex—the first ex-
ample of such a system inb-lactammetabolite biosyn-
thesis. Disruption of the mono-oxygenase-encoding
gene, cvm5, led to the accumulation of the novel
clavam, 2-carboxymethylideneclavam, proposed to
function as an intermediate in 5S clavam biosynthesis.
In addition, 2-carboxymethylideneclavam is the first
metabolite to be identified in the 5S clavam biosyn-
thetic pathway beyond clavaminic acid. Further analy-
sis revealed that additional genes involved in the
biosynthesis of the 5S clavams are located in the
paralog, rather than the clavam gene cluster. A tran-
scriptional regulator was identified that functions as
a pathway-specific regulator for 5S clavammetabolitelsevier Ltd All rights reserved
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Name Oligonucleotide Sequence (50–30) Functiona
CAN 60 GGTCTGGTGCAGTGGAGCC Forward primer for cloning cvm9
CAN 65 TCCGCGTCCGATCGGGTCG Reverse primer for cloning cvm9
CVM2-FWD CCAGCACAGCCACCCGGAATCTCTGGAGGTCGTT
TCATTCCGGGGATCCGTCGACC
Forward primer for cvm2 REDIRECT mutagenesis
CVM2-REV CCGGAGGCCGGGTCACAGCCACGGGTAACGCGC
GGTGTCTGTAGGCTGGAGCTGCTTC
Reverse primer for cvm2 REDIRECT mutagenesis
CVM12-FWD CGGGAAGCGGTCCACCGGACAGGGGAGGTACGG
GAGATGATTCCGGGGATCCGTCGACC
Forward primer for cvm12 REDIRECT mutagenesis
CVM12-REV GCCCGCCCGGCGCGCTCAGTCCAGGGCCAGGTC
CTCCGGTGTAGGCTGGAGCTGCTTC
Reverse primer for cvm12 REDIRECT mutagenesis
CVM13-FWD CGGAGCGTCTCTCACCCCCGTCCCGAGGAGTGC
CCGATGATTCCGGGGATCCGTCGACC
Forward primer for cvm13 REDIRECT mutagenesis
CVM13-REV GTCAGGCCCGCAGGCAGCCACCGGTCGGCGGGC
GGATCATGTAGGCTGGAGCTGCTTC
Reverse primer for cvm13 REDIRECT mutagenesis
CVM7P-FOR GGCGCCGTCAGCCACGCAGAGAAGATCGGATAC
GCAGTGATTCCGGGGATCCGTCG
Forward primer for cvm7P REDIRECT mutagenesis
CVM7P-REV GCGCCGCCCGCCGCCGAGGACCCCGGGGCCCGG
GACTCATGTAGGCTGGAGCTGCT
Reverse primer for cvm7P REDIRECT mutagenesis
GRA-FWD GCACCCGCCGGACGGACGCCCTCGGCACATGCC
CCGGTGATTCCGGGGATCCGTCGACC
Forward primer for cvmG REDIRECT mutagenesis
GRA-REV GCCGGCCGGAGAGCTGGGCTCCGGTGCTGCGGG
GCCTCATGTAGGCTGGAGCTGCTTC
Reverse primer for cvmG REDIRECT mutagenesis
HYD-FWD TCCCGACCGCTCCACTCCCCAGGAGTCCGCCCGAT
GGTG ATTCCGGGGATCCGTCGACC
Forward primer for cvmH REDIRECT mutagenesis
HYD-REV GCCCCCGGGCCCGACCCGGGTCAGCGCTGACCC
GGGTCATGTAGGCTGGAGCTGCTTC
Reverse primer for cvmH REDIRECT mutagenesis
PAD-FWD GTCCGGCCCACTCCCGCGTGCGAAAAGTCGCCC
ACTGTGATTCCGGGGATCCGTCGACC
Forward primer for cvmP REDIRECT mutagenesis
PAD-REV CGGGACCCCGCGTTCACGCTGCCGCCCTGACCG
GTGTTCATGTAGGCTGGAGCTGCTTC
Reverse primer for cvmP REDIRECT mutagenesis
a The function of each oligonucleotide primer is described in detail under Experimental Procedures.biosynthesis—the first such regulator of 5S clavam
biosynthesis to be identified. A better understanding
of the biochemical pathway leading to the 5S clavam
metabolites and, in particular, the enzymatic activities
responsible for forming the C2 side chains of the 5S
clavams may provide routes for the biological modifi-
cation of the clavulanic acid C2 side chain. In addition,
identification of the full complement of biosynthetic
and regulatory genes needed for production of the 5S
clavams, and elucidation of their interactions with
clavulanic acid production, could provide further in-
sight into the evolution and regulation of related antibi-
otic biosynthetic pathways. Such an understanding
could impact rational strain improvement and combi-
natorial biosynthesis methodologies, whereby multi-
ple antibiotic gene clusters could be introduced into
the sameorganismandmanipulated to produce useful
compounds.Chemistry & Biology 14, 131–1EXPERIMENTAL PROCEDURES
Bacterial Strains and Culture Conditions
S. clavuligerus NRRL3585 and S. lividans TK24 [41] were used in this
study. Wild-type and mutant S. clavuligerus strains were maintained
on either MYM [42] or ISP-4 (Difco) medium. AS-1medium [43] supple-
mented with 10 mM MgCl2 was used in the isolation of S. clavuligerus
exconjugants. Trypticase soy broth supplemented with 1% soluble
starch (TSBS) was used to grow S. clavuligerus cultures for seeding
and plasmid/chromosomal DNA isolation. Soy fermentation medium,
composed largely of soy flour and starch, was used to assay antibiotic
production [12]. S. lividans was maintained on either R5 or MYM
medium, and grown in TSB liquid culture to isolate plasmid DNA
[41]. Streptomyces plasmid-bearing cultures were supplemented
with apramycin (50 mg ml1 for S. lividans and 25 mg ml1 for
S. clavuligerus), neomycin (60 mg ml1 for S. lividans and 50 mg ml1
for S. clavuligerus), or thiostrepton (50 mg ml1 for S. lividans and
5 mg ml1 for S. clavuligerus). All Streptomyces spp. cultures were
propagated at 28C on a rotary shaker at 250 rpm.
Escherichia coliDH5a (GIBCOBRL) and XL1-Blue (Stratagene) were
used as host strains for cloning, and were grown on Luria broth (LB)42, February 2007 ª2007 Elsevier Ltd All rights reserved 139
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by Dr. R. Losick (Harvard University, Cambridge, MA) was used
to isolate nonmethylated plasmid DNA for transformation into Strepto-
myces spp. E. coli ET12567 (pUZ8002) was used for intergeneric
conjugation of plasmid/cosmid DNA into Streptomyces spp [41].
DNA Manipulation and Southern Hybridization
Standard procedures, including transformation, restriction analysis,
blunting of fragments, subcloning, and labeling with [a-32P]dCTP
by nick translation, were used for manipulating plasmid DNA isolated
from E. coli [44]. Southern hybridization and washing of membranes
were carried out at 65C, as previously described [44]. Plasmid
and chromosomal DNA was isolated from Streptomyces spp. by pre-
viously described procedures [41]. Preparation and transformation of
S. lividans [41] and S. clavuligerus [45] protoplasts were performed
as described previously. Unmethylated plasmid DNA isolated from
E. coli ER1447was passaged through S. lividans before transformation
into S. clavuligerus. Introduction of cosmid DNA into S. clavuligerus
by conjugation was carried out as described previously [18].
PCRs using oligonucleotide primers listed in Table 2 were carried
out using the Expand high-fidelity PCR system according to the
manufacturer’s instructions (Roche).
DNA Sequence Analysis
The cosmids p53, from a pFD666-based [46] library containing
S. clavuligerus chromosomal DNA (Jensen et al. unpublished data),
and 10D7 [19] were used to isolate DNA fragments to extend the
sequence of the clavam cluster beyond the previously sequenced
cvm3 and cvm6 genes. The region of the S. clavuligerus chromosome
downstream of oat1 [18] from the paralog gene cluster was also
sequenced. The plasmids pO4H4 and pO4H5 [16] were used to obtain
the sequence of the 30-end of cvm6P. A 5.24 kbNcoI fragment from the
cosmid 14E10 [16]was sequenced using universal and customprimers
to yield the 50-end of cvm6P as well as cvm7P. Some sequence infor-
mation was also obtained directly using cosmid 14E10 as template to
complete the double-stranded DNA sequence of cvm6P and cvm7P.
DNA sequencing was carried out by the Molecular Biology Service
Unit, University of Alberta (AB, Canada). ORFs were predicted based
on codon preference with the online program Frame Plot 2.3.2 (http://
www.nih.go.jp/jun/cgi-bin/frameplot.pl) and similarity searches were
performed using the BLAST program (http://www.ncbi.nlm.nih.gov/
BLAST/).
Preparation of Mutants
Mutants with defects in genes from the region surrounding the clavam
cluster were prepared either by insertion of antibiotic resistance cas-
settes into appropriate restriction endonuclease sites within cloned
copies of the genes, or, more recently, by PCR-targeted mutagenesis
[28]. Genes mutated by the former procedures include cvm3 (apr in-
serted into an NcoI site 140 bp from the start codon), cvm4 (neo in-
serted into a BclI site 284 bp from the start codon), cvm5 (apr inserted
into a BsaBI site 772 bp from the start codon), cvm6 (apr inserted into
a BstEII site 158 bp from the start codon), cvm7-50 end (apr inserted
into a ClaI site 130 bp from the start codon), cvm7-30 end (apr inserted
into an NcoI site 2064 bp from the start codon), cvm9 (apr inserted in
the PflMI site 234 bp from the start codon), cvm10 (apr inserted in
the XcmI site 239 bp from the start codon), and cvm11 (apr inserted
in the NcoI site 344 bp from the start codon). In each case, once the
subcloned gene had been disrupted within an E. coli-based plasmid,
the disrupted gene was either transferred to the Streptomyces-based
plasmid, pIJ486, or the entire plasmid construct was fused to pIJ486
to create a shuttle vector. The disruption constructs were then trans-
formed into S. clavuligerus, where the wild-type gene was replaced
by the disrupted allele, as described previously [11].
The cvmP, cvm2, cvm12, cvm13, and cvmGmutantswere prepared,
and creation of a cvmH mutant was attempted, with the cosmid p53
and the previously described PCR-targetingmethod [28]. Due to struc-
tural instability of cosmid p53 and its derivatives, fragments carrying140 Chemistry & Biology 14, 131–142, February 2007 ª2007 Ethe disrupted genes were subcloned into pUWL-KS [47] for conjuga-
tion into S. clavuligerus to generate mutants.
Mutants defective in cvm6P were prepared using an approximately
1 kb EcoRI/PstI fragment encoding neo, isolated from pFDNeo-S [46].
This fragment was inserted into a subcloned copy of cvm6P, 708 bp
from the start codon, in place of a native EcoNI fragment. The neo-
disrupted cvm6P was transferred into the shuttle vector pUWL-KS,
which was then transformed into S. clavuligerus.
S. clavuligerus cvm7P mutants were prepared using PCR targeting
in cosmid 14E10 [28]. All of the mutants prepared in this study were
verified by Southern analysis and/or PCR.
HPLC, MS, Bioassays, and Growth Assays
Supernatants or solid media extracts from S. clavuligerus cultures
grown on soy medium were analyzed by HPLC to measure clavulanic
acid and 5S clavam production using previously described conditions
[48]. When novel peaks were observed, culture supernatants were also
analyzed by LC-MS using conditions described previously [12]. Soft
ESI-MS analysis to obtain fragmentation data for unknown identifica-
tion was performed as described previously [7].
Bioassays were also used to monitor clavulanic acid, alanylclavam,
and cephamycin C production under previously described conditions
[12].
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